Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer
July 12, 2021 08:00 ET
|
Opiant Pharmaceuticals, Inc.
Mr. Ruth led the highly successful launch and commercialization of the first FDA-approved nasal naloxone spray to treat opioid overdoseHe joins Opiant at a time when the Company is developing and...
CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of Directors
July 12, 2021 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, July 12, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
LAWSUIT FILED: Rekor Systems Sued for Securities Fraud; Investors Should Contact Block & Leviton for More Information
July 12, 2021 08:00 ET
|
Block & Leviton LLP
BOSTON, July 12, 2021 (GLOBE NEWSWIRE) -- Block & Leviton announces that a class action lawsuit has been filed against Rekor Systems, Inc. (NASDAQ: REKR) f/k/a Novume Solutions, Inc. (NVMM) and...
FuelCell Energy Receives Court Case Win in the Court of Chancery in Delaware Versus Posco Energy
July 12, 2021 08:00 ET
|
FuelCell Energy, Inc.
DANBURY, Conn., July 12, 2021 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) -- a global leader in fuel cell technology with a purpose of utilizing its proprietary, state-of-the-art fuel...
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
July 12, 2021 08:00 ET
|
OPKO Health, Inc.
MIAMI, July 12, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced it has entered into an exclusive worldwide agreement with privately held CAMP4 Therapeutics Corporation...
Sientra Announces Appointment of Chief Financial Officer
July 12, 2021 08:00 ET
|
Sientra, Inc.
SANTA BARBARA, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced...
Kymera Therapeutics Presents New Preclinical Data on STAT3 Degraders Showing Antitumor Activity in STAT3 Mutant and Wild-Type Peripheral T-Cell Lymphoma at 13th Annual T-Cell Lymphoma Forum
July 12, 2021 08:00 ET
|
Kymera Therapeutics, Inc.
Data demonstrate Kymera’s ability to degrade mutant and wild-type STAT3, a traditionally “undruggable” target, and the broad therapeutic potential for the treatment of peripheral T-cell lymphoma...
Avaap Named Among IDG Insider Pro and Computerworld’s Best Places to Work for the Eighth Consecutive Year
July 12, 2021 08:00 ET
|
Avaap Inc.
COLUMBUS, Ohio, July 12, 2021 (GLOBE NEWSWIRE) -- Avaap, a fast-growing Workday Services Partner and management consulting organization with an emphasis on transformation services, including...
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Seborrheic Dermatitis
July 12, 2021 08:00 ET
|
Arcutis Biotherapeutics, Inc.
Topical roflumilast potential “Best-in-Class” topical PDE4 inhibitorSeborrheic dermatitis affects 10 million patients in the U.S.Potential first new topical treatment for seborrheic dermatitis in...
LGBTQ Loyalty Welcomes its First Trans Member to Board of Directors
July 12, 2021 08:00 ET
|
LGBTQ Loyalty Holdings, Inc.
CEO of RebelMouse and Former CTO of The Huffington Post, Andrea Breanna, joins LGBTQ Loyalty Holding’s all-star line-up of board members and champions WEST HOLLYWOOD, Calif., July 12, 2021 (GLOBE...
- September 23, 2024 03:05 ET LIFT reports laboratory metallurgical recoveries averaging 79% producing a high-quality spodumene concentrate grading 5.83% Li2O at the Yellowknife Lithium Project
- September 23, 2024 02:20 ET Bitget and Foresight Ventures Invest $30 Million in TON Blockchain to Accelerate Growing Telegram-based Projects